Jianfeng Group Pro 2017-025 (Announcement on Changes in the Company's Accounting Policy)
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2017-025
Bond Abbreviations: 13 Peak 01 Bond Code: 122227
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Changes in the Company's Accounting Policy
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .
Important Note:
● This change in the Company's accounting policy will only have an impact on the presentation of items in the financial statements, and will not have an impact on the Company's net assets and net profit, and will not involve retrospective adjustments from previous years.
1. Overview of this Accounting Policy Change
On April 28, 2017 , the Ministry of Finance formulated and issued Accounting Standards for Business Enterprises No. 42-Non-current Assets Held for Sale, Disposal Group and Discontinued Operations (Accounting [2017 ] No. 13 ) , on May 10, 2017 , the "Accounting Standards for Enterprises No. 16-Government Subsidies" (Accounting [2017 ] No. 15 ) was revised and issued, requiring all enterprises implementing the Accounting Standards for Enterprises to be implemented from May 28, 2017 and June 12, 2017 respectively.
Before this change, the company implemented the "Accounting Standards for Business Enterprises-Basic Standards" issued by the Ministry of Finance on February 15, 2006 and 38 specific accounting standards, application guidelines for accounting standards for business enterprises, interpretation announcements for accounting standards for business enterprises and subsequent revisions. Specific standards and other relevant regulations.
to implement the above revised accounting standards, the company intends to make corresponding changes to the accounting policy, the remaining unchanged part of the Ministry of Finance on February 15, 2006 and subsequent amendments to the relevant specific standards and other relevant provisions.
2. The specific situation of this accounting policy change and its impact on the company
(I) According to the regulations and requirements of the Ministry of Finance on the issuance of <Accounting Standard No. 42-Non-current Assets Held for Sale, Disposal Group and Termination of Operations> (Caikuai [2017] No. 13), implement ASU 42-Non-current Assets Held for Sale, Disposal Groups and Discontinued Operations, and make corresponding disclosures in the financial statements as required. The Company's implementation of the above new standards will not have an impact on the Company's total assets, total liabilities, net assets and net income for the current period and prior to the change in accounting policy.
(II) According to the notice issued by the Ministry of Finance on the revision of the "Accounting Standards for Business Enterprises No. 16 -Government Subsidies" (Caihui [2017] No. 15), the company will modify the presentation of the financial statements and report the "other income" account separately above the "operating profit" item in the income statement, reclassify government grants related to the Company's daily activities from January 1, 2017 from "non-operating income" to "other income. The Company applies the prospective application method to government grants that existed on January 1, 2017, and adjusts new government grants between January 1, 2017 and the effective date of the new standard in accordance with the new government grant standard, with no retrospective adjustment to the financial statements for comparable accounting periods. With this adjustment, the amount of "other income" will increase by 5,829,838.47 yuan and the amount of "non-operating income" will decrease by 5,829,838.47 yuan during the reporting period.
3. Board of Directors Review
The company held the 15th meeting of the 9th Board of Directors on August 25, 2017 to review and pass the "Proposal on Changes in the Company's Accounting Policy". The voting result: 9 votes in favor, 0 votes against, and 0 abstentions.
The Board of Directors of the Company believes that this change in accounting policy is a reasonable adjustment in accordance with the relevant regulations of the Ministry of Finance, and that the implementation of the changed accounting policy can objectively and fairly reflect the Company's financial position and operating results, providing investors with more reliable and accurate accounting information. This change in accounting policy is in line with the actual situation of the company, in line with the "Enterprise Accounting Standards" and other relevant provisions, agreed to this change in accounting policy.
4. independent directors issued independent opinions
The independent directors of the company believe that the company's accounting policy change is a reasonable change made by the company in accordance with the requirements of relevant documents of the Ministry of Finance, and conforms to the Accounting Standards for Business Enterprises and related regulations, Its decision-making procedures comply with relevant laws, regulations and the company's "Articles of Association" and other provisions, and do not harm the interests of the company and small and minority shareholders.
5. Board of Supervisors Review Opinions
The Board of Supervisors believes that the company's accounting policy change is adjusted in accordance with changes in national policies and complies with the revised "Accounting Standards for Business Enterprises No. 16 -Government Subsidy" (Accounting [2017] No. 15) and other relevant regulations, the change decision-making procedures also comply with relevant laws, administrative regulations and the "Articles of Association, there is no harm to the interests of shareholders, especially small and medium-sized shareholders. Agree to the company's accounting policy changes.
6. Reference Document
(I) Opinions of Independent Directors of Jianfeng Group;
Resolutions of the 12th Board of Supervisors of the 8th 94th Session of (II) Jianfeng Group;
Resolutions of the 15th Session of the 9th 97th Session of (III) Jianfeng Group;hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
August 29, 2017
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31